Clinical Research
BioAgilytix Closes Acquisition of Australia-based 360biolabs®
360biolabs®, the most comprehensive contract research organization in Australia and New Zealand, has now officially joined forces with BioAgilytix Labs...
October 14, 2021 | News
Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease
News Facts:- Fujitsu and the University of Tokyo Hospital validate the effectiveness of proprietary AI technology that uses electrocardiographic data...
October 11, 2021 | News
Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial
Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...
September 21, 2021 | News
Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody
The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...
September 14, 2021 | News
HaemaLogiX raises $10 million to advance multiple myeloma treatments
HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Asset Management as core new institutional investor w...
September 09, 2021 | News
Odyssey Group Approved to Start Human Trial to Treat Concussion
The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...
September 08, 2021 | News
Stem Cells for Everyone: I Peace expands its clinical-grade
I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of ...
September 08, 2021 | News
NuProbe Enables Rapid Ultrasensitive Mutation Detection
he method, termed oncogene concatenated enriched amplicon nanopore sequencing (OCEANS), enables rapid, accurate, and affordable detection of somatic mutati...
September 07, 2021 | News
Cough monitoring smartphone app incorporated into year-long respiratory research trial
Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, rece...
August 31, 2021 | News
BioAgilytix to Purchase Australia-based 360biolabs®
BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all sta...
August 17, 2021 | News
InxMed's IN10018 Receives U.S. FDA Fast Track Designation
InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with inte...
August 16, 2021 | News
Clarivate Acquires Bioinfogate
Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customer...
August 05, 2021 | News
$3.3 million to support Australians living with a rare disease
The Morrison Government is providing $3.3 million to support the approximate two million Australians living with a rare disease, providing them with suppor...
August 02, 2021 | News
Curia to Acquire US-Based LakePharma
Adds integrated biologics development platform from discovery through GMP manufacturing Curia, formerly AMRI, a leading contract research, development and...
July 19, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
